The wildly beating heart, fatigue and other debilitating symptoms are well known to the many millions of people impacted by atrial fibrillation. Some of those who have afib may have no outward symptoms, but are still at risk of serious and long-term damage to the heart. Symptoms or not, rate control is the common treatment …
Read More
StopAfib.org interviews Dr. Daniel Singer of Harvard Medical School. Find more information on this topic, and Dr. Singer, at: http://www.stopafib.org/newsitem.cfm/NEWSID/397 Dr. Singer led a symposium on atrial fibrillation stroke prevention at Boston Atrial Fibrillation Symposium 2012. In this video interview, Dr. Singer shared with StopAfib.org information from that symposium. He provided an update on rivaroxaban …
Read More
StopAfib.org interviews Dr. Daniel Singer, of Harvard Medical School. Find more information on this topic, Dr. Singer, and a transcript of the interview, at: http://stopafib.org/newsitem.cfm/NEWSID/394 In this video interview, Dr. Singer discussed topics covered in the stroke prevention in atrial fibrillation symposium he moderated at the Boston AF Symposium 2011. The topics discussed included the …
Read More
In this interview, Dr. Daniel Singer updates us on the new anticoagulants for atrial fibrillation stroke prevention that he presented about at Boston Atrial Fibrillation Symposium. He provided an update on rivaroxaban (Xarelto), apixaban (Eliquis), dabigatran (Pradaxa), and edoxaban, and mentioned that all were better than warfarin (Coumadin) in preventing intracranial bleeding (bleeding in the …
Read More
At Boston Atrial Fibrillation Symposium 2012, Dr. Hugh Calkins, electrophysiologist at Johns Hopkins, presented the new 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation, which will replace the original guidelines that were published in 2007. Instead of simply rewriting sections that have changed, the writing committee, which was made up …
Read More
Dr. John Mandrola, a cardiac electrophysiologist in Louisville, Kentucky, who blogs at Dr. John M, live-blogged the 2012 Boston Atrial Fibrillation Symposium. He has given us permission to reprint his blog posts for the afib community. You will find them here: Recap of Boston Atrial Fibrillation Symposium 2012 – Guest Posts by Dr. John Mandrola …
Read More
StopAfib.org interviews Dr. Sanjiv Narayan of the University of California at San Diego. Find a transcript of the interview, and more on Dr. Narayan and the FIRM trial at: http://www.stopafib.org/newsitem.cfm/NEWSID/379 In this video interview at the American Heart Association Scientific Sessions 2011, Dr. Narayan discussed the high success rate of the FIRM trial of focal …
Read More
StopAfib.org interviews Prof. Gregory Lip, of the University of Birmingham (UK) Find more information on the CHADS2 scoring system, and on Prof. Lip, at: http://www.stopafib.org/newsitem.cfm/NEWSID/369 In this video interview, Dr. Lip discussed the CHA2DS2-VASc tool, which was recently adopted by the European Society of Cardiology Atrial Fibrillation Guidelines for predicting stroke risk in atrial fibrillation. …
Read More
StopAfib.org interviews Dr. John Mandrola of Baptist Hospital East in Louisville, KY. Trancripts and more information on Dr. Mandrola are available at: http://www.stopafib.org/newsitem.cfm/NEWSID/374 In this video interview at the American Heart Association Scientific Sessions 2011, Dr. John Mandrola discussed the poster he presented there about gender-specific results of atrial fibrillation ablation in a private practice …
Read More
StopAfib.org interviews Dr. Elaine Hylek of Boston University. A transcript of this video, as well as additional information about the topics discussed, and Dr. Hylek, can be found at: http://www.stopafib.org/newsitem.cfm/NEWSID/349 In this video interview, Dr. Elaine Hylek of Boston University discusses new anticoagulant drugs for stroke prevention in atrial fibrillation. For many years, warfarin (Coumadin) …
Read More